The Icahn School of Medicine at Mount Sinai in New York City has become the first medical school in the U.S. to provide institutionwide access to ChatGPT Edu — a secure version of the tool designed for universities.
The medical school is offering ChatGPT Edu to all medical and graduate students, along with select faculty and staff. The move represents a significant shift in Mount Sinai’s efforts to incorporate artificial intelligence tools into medical education and training.
“At Mount Sinai, we believe it’s our responsibility not just to adopt emerging technologies, but to do so with care, purpose and a strong commitment to equity and academic integrity,” David Thomas, MD, dean for medical education at the Icahn School of Medicine, said in a May 5 news release. “It’s about helping [students] build the judgment, skills and ethical grounding they’ll need to lead in a future where AI will increasingly intersect with medicine.”
Students are trained to use ChatGPT as a complement — not replacement — to evidence-based medicine and expert guidance. Mount Sinai described the tool as a “digital study partner,” helping students understand complex cases, conduct data analysis for research and get assistance with coding, among other use cases. Faculty members are also exploring how to use the tool to improve curriculum.
The tool includes robust safeguards to ensure responsible use and is fully HIPAA compliant. Mount Sinai Health System said it plans to expand access to additional teaching and learning groups across the health system in the coming months.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
